Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis.
Zheng, Haofeng
Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis. [electronic resource] - BioMed research international 2017 - 8050313 p. digital
Publication Type: Journal Article
2314-6141
10.1155/2017/8050313 doi
Antineoplastic Agents--pharmacology
Cell Line, Tumor
ErbB Receptors--antagonists & inhibitors
Gene Expression Regulation, Neoplastic--genetics
Humans
Male
Molecular Targeted Therapy
Neoplasm Proteins--genetics
Prostatic Neoplasms--drug therapy
Protein Interaction Maps--genetics
Signal Transduction--drug effects
Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis. [electronic resource] - BioMed research international 2017 - 8050313 p. digital
Publication Type: Journal Article
2314-6141
10.1155/2017/8050313 doi
Antineoplastic Agents--pharmacology
Cell Line, Tumor
ErbB Receptors--antagonists & inhibitors
Gene Expression Regulation, Neoplastic--genetics
Humans
Male
Molecular Targeted Therapy
Neoplasm Proteins--genetics
Prostatic Neoplasms--drug therapy
Protein Interaction Maps--genetics
Signal Transduction--drug effects